{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Helicobacter pylori infection", "herbal treatment", "peptic ulcer disease"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30717467", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "02", "Day": "03"}], "Language": ["eng"], "ELocationID": ["179", "10.3390/jcm8020179"], "Journal": {"ISSN": "2077-0383", "JournalIssue": {"Volume": "8", "Issue": "2", "PubDate": {"Year": "2019", "Month": "Feb", "Day": "03"}}, "Title": "Journal of clinical medicine", "ISOAbbreviation": "J Clin Med"}, "ArticleTitle": "Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options.", "Abstract": {"AbstractText": ["Peptic ulcer is a chronic disease affecting up to 10% of the world's population. The formation of peptic ulcers depends on the presence of gastric juice pH and the decrease in mucosal defenses. Non-steroidal anti-inflammatory drugs (NSAIDs) and <i>Helicobacter pylori (H. pylori)</i> infection are the two major factors disrupting the mucosal resistance to injury. Conventional treatments of peptic ulcers, such as proton pump inhibitors (PPIs) and histamine-2 (H2) receptor antagonists, have demonstrated adverse effects, relapses, and various drug interactions. On the other hand, medicinal plants and their chemical compounds are useful in the prevention and treatment of numerous diseases. Hence, this review presents common medicinal plants that may be used for the treatment or prevention of peptic ulcers."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. lucija.kuna@fdmz.hr."}], "LastName": "Kuna", "ForeName": "Lucija", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology and Physiology with Immunology, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. jelena.jakab@fdmz.hr."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. jelena.jakab@fdmz.hr."}], "LastName": "Jakab", "ForeName": "Jelena", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology and Physiology with Immunology, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. robert.smolic@fdmz.hr."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. robert.smolic@fdmz.hr."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, University Hospital Osijek, 31000 Osijek, Croatia. robert.smolic@fdmz.hr."}], "LastName": "Smolic", "ForeName": "Robert", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. nikola.rlucic@gmail.com."}], "LastName": "Raguz-Lucic", "ForeName": "Nikola", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathophysiology and Physiology with Immunology, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. aleksandar.vcev@fdmz.hr."}, {"Identifier": [], "Affiliation": "Department of Internal Medicine, University Hospital Osijek, 31000 Osijek, Croatia. aleksandar.vcev@fdmz.hr."}], "LastName": "Vcev", "ForeName": "Aleksandar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. martina.smolic@mefos.hr."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia. martina.smolic@mefos.hr."}], "LastName": "Smolic", "ForeName": "Martina", "Initials": "M"}], "GrantList": [{"GrantID": "VIF-2017-MEFOS-5 (to M.S.) and VIF-2017-MEFOS-2 (to A.V.)", "Agency": "Croatian Ministry of Science, Education and Sports", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Clin Med", "NlmUniqueID": "101606588", "ISSNLinking": "2077-0383"}, "CoiStatement": "The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Narayanan M., Reddy K.M., Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Mo. Med. 2018;115:219\u2013224.", "ArticleIdList": ["PMC6140150", "30228726"]}, {"Citation": "Lanas A., Chan F.K.L. Peptic ulcer disease. Lancet. 2017;390:613\u2013624. doi: 10.1016/S0140-6736(16)32404-7.", "ArticleIdList": ["10.1016/S0140-6736(16)32404-7", "28242110"]}, {"Citation": "Lanas A., Garc\u00eda-Rodr\u00edguez L.A., Polo-Tom\u00e1s M., Ponce M., Quintero E., Perez-Aisa M.A., Gisbert J.P., Bujanda L., Castro M., Mu\u00f1oz M., et al. The changing face of hospitalisation due to gastrointestinal bleeding and perforation. Aliment. Pharmacol. Ther. 2011;33:585\u2013591. doi: 10.1111/j.1365-2036.2010.04563.x.", "ArticleIdList": ["10.1111/j.1365-2036.2010.04563.x", "21205256"]}, {"Citation": "Sonnenberg A. Review article: Historic changes of helicobacter pylori-associated diseases. Aliment. Pharmacol. Ther. 2013;38:329\u2013342. doi: 10.1111/apt.12380.", "ArticleIdList": ["10.1111/apt.12380", "23786250"]}, {"Citation": "S\u00f8reide K., Thorsen K., Harrison E.M., Bingener J., M\u00f8ller M.H., Ohene-Yeboah M., S\u00f8reide J.A. Perforated peptic ulcer. Lancet. 2015;386:1288\u20131298. doi: 10.1016/S0140-6736(15)00276-7.", "ArticleIdList": ["10.1016/S0140-6736(15)00276-7", "PMC4618390", "26460663"]}, {"Citation": "Zhang B.B., Li Y., Liu X.Q., Wang P.J., Yang B., Bian D.L. Association between vacA genotypes and the risk of duodenal ulcer: A meta-analysis. Mol. Biol. Rep. 2014;41:7241\u20137254. doi: 10.1007/s11033-014-3610-y.", "ArticleIdList": ["10.1007/s11033-014-3610-y", "25063579"]}, {"Citation": "Datta De D., Roychoudhury S. To be or not to be: The host genetic factor and beyond in Helicobacter pylori mediated gastro-duodenal diseases. World J. Gastroenterol. 2015;21:2883\u20132895. doi: 10.3748/wjg.v21.i10.2883.", "ArticleIdList": ["10.3748/wjg.v21.i10.2883", "PMC4356907", "25780285"]}, {"Citation": "Lanas \u00c1., Carrera-Lasfuentes P., Arguedas Y., Garc\u00eda S., Bujanda L., Calvet X., Ponce J., Perez-A\u00edsa \u00c1., Castro M., Mu\u00f1oz M., et al. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. Clin. Gastroenterol. Hepatol. 2015;13:906\u2013912.e2. doi: 10.1016/j.cgh.2014.11.007.", "ArticleIdList": ["10.1016/j.cgh.2014.11.007", "25460554"]}, {"Citation": "Masclee G.M., Valkhoff V.E., Coloma P.M., de Ridder M., Romio S., Schuemie M.J., Herings R., Gini R., Mazzaglia G., Picelli G., et al. Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology. 2014;147:784\u2013792. doi: 10.1053/j.gastro.2014.06.007.", "ArticleIdList": ["10.1053/j.gastro.2014.06.007", "24937265"]}, {"Citation": "Huang J.Q., Sridhar S., Hunt R.H. Role of helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: A meta-analysis. Lancet. 2002;359:14\u201322. doi: 10.1016/S0140-6736(02)07273-2.", "ArticleIdList": ["10.1016/S0140-6736(02)07273-2", "11809181"]}, {"Citation": "Charpignon C., Lesgourgues B., Pariente A., Nahon S., Pelaquier A., Gatineau-Sailliant G., Roucayrol A.M., Courillon-Mallet A., Group de l\u2019Observatoire National des Ulc\u00e8res de l\u2019Association Nationale des H\u00e9patoGastroent\u00e9rologues des H\u00f4pitaux G\u00e9n\u00e9raux (ANGH) Peptic ulcer disease: One in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment. Pharmacol. Ther. 2013;38:946\u2013954. doi: 10.1111/apt.12465.", "ArticleIdList": ["10.1111/apt.12465", "23981105"]}, {"Citation": "Levenstein S., Rosenstock S., Jacobsen R.K., Jorgensen T. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin. Gastroenterol. Hepatol. 2015;13:498\u2013506.e1. doi: 10.1016/j.cgh.2014.07.052.", "ArticleIdList": ["10.1016/j.cgh.2014.07.052", "25111233"]}, {"Citation": "McColl K.E. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer. Gastroenterol. Clin. N. Am. 2009;38:353\u2013361. doi: 10.1016/j.gtc.2009.03.004.", "ArticleIdList": ["10.1016/j.gtc.2009.03.004", "19446263"]}, {"Citation": "Siddique O., Ovalle A., Siddique A.S., Moss S.F. Helicobacter pylori infection: An update for the internist in the age of increasing global antibiotic resistance. Am. J. Med. 2018;131:473\u2013479. doi: 10.1016/j.amjmed.2017.12.024.", "ArticleIdList": ["10.1016/j.amjmed.2017.12.024", "29353050"]}, {"Citation": "Hooi J.K.Y., Lai W.Y., Ng W.K., Suen M.M.Y., Underwood F.E., Tanyingoh D., Malfertheiner P., Graham D.Y., Wong V.W.S., Wu J.C.Y., et al. Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology. 2017;153:420\u2013429. doi: 10.1053/j.gastro.2017.04.022.", "ArticleIdList": ["10.1053/j.gastro.2017.04.022", "28456631"]}, {"Citation": "Zaki M., Coudron P.E., McCuen R.W., Harrington L., Chu S., Schubert M.L. H. Pylori acutely inhibits gastric secretion by activating CGRP sensory neurons coupled to stimulation of somatostatin and inhibition of histamine secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 2013;304:G715\u2013G722. doi: 10.1152/ajpgi.00187.2012.", "ArticleIdList": ["10.1152/ajpgi.00187.2012", "23392237"]}, {"Citation": "El-Omar E.M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., Williams C., Ardill J.E., McColl K.E. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 1997;113:15\u201324. doi: 10.1016/S0016-5085(97)70075-1.", "ArticleIdList": ["10.1016/S0016-5085(97)70075-1", "9207257"]}, {"Citation": "Moss S.F., Legon S., Bishop A.E., Polak J.M., Calam J. Effect of helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet. 1992;340:930\u2013932. doi: 10.1016/0140-6736(92)92816-X.", "ArticleIdList": ["10.1016/0140-6736(92)92816-X", "1357347"]}, {"Citation": "Bhala N., Emberson J., Merhi A., Abramson S., Arber N., Baron J.A., Bombardier C., Cannon C., Farkouh M.E., FitzGerald G.A., et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769\u2013779.", "ArticleIdList": ["PMC3778977", "23726390"]}, {"Citation": "Bjarnason I., Scarpignato C., Takeuchi K., Rainsford K.D. Determinants of the short-term gastric damage caused by NSAIDs in man. Aliment. Pharmacol. Ther. 2007;26:95\u2013106. doi: 10.1111/j.1365-2036.2007.03348.x.", "ArticleIdList": ["10.1111/j.1365-2036.2007.03348.x", "17555426"]}, {"Citation": "M\u00f6ssner J. The indications, applications, and risks of proton pump inhibitors. Dtsch. Arztebl. Int. 2016;113:477\u2013483. doi: 10.3238/arztebl.2016.0477.", "ArticleIdList": ["10.3238/arztebl.2016.0477", "PMC4973002", "27476707"]}, {"Citation": "Maes M.L., Fixen D.R., Linnebur S.A. Adverse effects of proton-pump inhibitor use in older adults: A review of the evidence. Ther. Adv. Drug Saf. 2017;8:273\u2013297. doi: 10.1177/2042098617715381.", "ArticleIdList": ["10.1177/2042098617715381", "PMC5557164", "28861211"]}, {"Citation": "Pension J., Wormsley K.G. Adverse reactions and interactions with H2-receptor antagonists. Med. Toxicol. 1986;1:192\u2013216. doi: 10.1007/BF03259837.", "ArticleIdList": ["10.1007/BF03259837", "2878343"]}, {"Citation": "Maton P.N., Burton M.E. Antacids revisited: A review of their clinical pharmacology and recommended therapeutic use. Drugs. 1999;57:855\u2013870. doi: 10.2165/00003495-199957060-00003.", "ArticleIdList": ["10.2165/00003495-199957060-00003", "10400401"]}, {"Citation": "Mizokami Y., Oda K., Funao N., Nishimura A., Soen S., Kawai T., Ashida K., Sugano K. Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: Randomised, lansoprazole-controlled non-inferiority and single-blind extension study. Gut. 2018;67:1042\u20131051. doi: 10.1136/gutjnl-2017-314010.", "ArticleIdList": ["10.1136/gutjnl-2017-314010", "PMC5969369", "28988197"]}, {"Citation": "Yamasaki A., Yoshio T., Muramatsu Y., Horiuchi Y., Ishiyama A., Hirasawa T., Tsuchida T., Sasaki Y., Fujisaki J. Vonoprazan is superior to rabeprazole for healing endoscopic submucosal dissection: Induced ulcers. Digestion. 2018;97:170\u2013176. doi: 10.1159/000485028.", "ArticleIdList": ["10.1159/000485028", "29310111"]}, {"Citation": "Kawai T., Oda K., Funao N., Nishimura A., Matsumoto Y., Mizokami Y., Ashida K., Sugano K. Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: Randomised phase 3 study. Gut. 2018;67:1033\u20131041. doi: 10.1136/gutjnl-2017-314852.", "ArticleIdList": ["10.1136/gutjnl-2017-314852", "PMC5969345", "29196436"]}, {"Citation": "Kagawa T., Iwamuro M., Ishikawa S., Ishida M., Kuraoka S., Sasaki K., Sakakihara I., Izumikawa K., Yamamoto K., Takahashi S., et al. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers. Aliment. Pharmacol. Ther. 2016;44:583\u2013591. doi: 10.1111/apt.13747.", "ArticleIdList": ["10.1111/apt.13747", "27464849"]}, {"Citation": "Tsuchiya I., Kato Y., Tanida E., Masui Y., Kato S., Nakajima A., Izumi M. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial. Dig. Endosc. 2017;29:576\u2013583. doi: 10.1111/den.12857.", "ArticleIdList": ["10.1111/den.12857", "28267236"]}, {"Citation": "Marks I.N. Sucralfate-safety and side effects. Scand. J. Gastroenterol. Suppl. 1991;26:36\u201342. doi: 10.3109/00365529109093218.", "ArticleIdList": ["10.3109/00365529109093218", "1957123"]}, {"Citation": "Aubert J., Bejan-Angoulvant T., Jonville-Bera A.P. [pharmacology of misoprostol (pharmacokinetic data, adverse effects and teratogenic effects)] J. Gynecol. Obstet. Biol. Reprod. (Paris) 2014;43:114\u2013122. doi: 10.1016/j.jgyn.2013.11.006.", "ArticleIdList": ["10.1016/j.jgyn.2013.11.006", "24440131"]}, {"Citation": "Malfertheiner P., Megraud F., O\u2019Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T., Bazzoli F., Gasbarrini A., Atherton J., Graham D.Y., et al. Management of Helicobacter pylori infection-the maastricht V/Florence consensus report. Gut. 2017;66:6\u201330. doi: 10.1136/gutjnl-2016-312288.", "ArticleIdList": ["10.1136/gutjnl-2016-312288", "27707777"]}, {"Citation": "Chen P.Y., Wu M.S., Chen C.Y., Bair M.J., Chou C.K., Lin J.T., Liou J.M., Taiwan Gastrointestinal Disease and Helicobacter Consortium Systematic review with meta-analysis: The efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2016;44:427\u2013437. doi: 10.1111/apt.13712.", "ArticleIdList": ["10.1111/apt.13712", "27363687"]}, {"Citation": "Shiota S., Reddy R., Alsarraj A., El-Serag H.B., Graham D.Y. Antibiotic resistance of Helicobacter pylori among male united states veterans. Clin. Gastroenterol. Hepatol. 2015;13:1616\u20131624. doi: 10.1016/j.cgh.2015.02.005.", "ArticleIdList": ["10.1016/j.cgh.2015.02.005", "PMC6905083", "25681693"]}, {"Citation": "Graham D.Y., Lee Y.C., Wu M.S. Rational Helicobacter pylori therapy: Evidence-based medicine rather than medicine-based evidence. Clin. Gastroenterol. Hepatol. 2014;12:177\u2013186. doi: 10.1016/j.cgh.2013.05.028.", "ArticleIdList": ["10.1016/j.cgh.2013.05.028", "PMC3830667", "23751282"]}, {"Citation": "Fallone C.A., Chiba N., van Zanten S.V., Fischbach L., Gisbert J.P., Hunt R.H., Jones N.L., Render C., Leontiadis G.I., Moayyedi P., et al. The toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology. 2016;151:51\u201369. doi: 10.1053/j.gastro.2016.04.006.", "ArticleIdList": ["10.1053/j.gastro.2016.04.006", "27102658"]}, {"Citation": "Dore M.P., Lu H., Graham D.Y. Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016;65:870\u2013878. doi: 10.1136/gutjnl-2015-311019.", "ArticleIdList": ["10.1136/gutjnl-2015-311019", "26848181"]}, {"Citation": "Sun Q., Liang X., Zheng Q., Liu W., Xiao S., Gu W., Lu H. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter. 2010;15:233\u2013238. doi: 10.1111/j.1523-5378.2010.00758.x.", "ArticleIdList": ["10.1111/j.1523-5378.2010.00758.x", "20557366"]}, {"Citation": "Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. Acg clinical guideline: Treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 2017;112:212\u2013239. doi: 10.1038/ajg.2016.563.", "ArticleIdList": ["10.1038/ajg.2016.563", "28071659"]}, {"Citation": "Gisbert J.P., Calvet X. Review article: Rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2012;35:209\u2013221. doi: 10.1111/j.1365-2036.2011.04937.x.", "ArticleIdList": ["10.1111/j.1365-2036.2011.04937.x", "22129228"]}, {"Citation": "Strand D.S., Kim D., Peura D.A. 25 years of proton pump inhibitors: A comprehensive review. Gut Liver. 2017;11:27\u201337. doi: 10.5009/gnl15502.", "ArticleIdList": ["10.5009/gnl15502", "PMC5221858", "27840364"]}, {"Citation": "DaCosta DiBonaventura M., Yuan Y., Wagner J.S., L\u2019Italien G.J., Lescrauwaet B., Langley P. The burden of viral hepatitis C in Europe: A propensity analysis of patient outcomes. Eur. J. Gastroenterol. Hepatol. 2012;24:869\u2013877. doi: 10.1097/MEG.0b013e3283551dee.", "ArticleIdList": ["10.1097/MEG.0b013e3283551dee", "22617367"]}, {"Citation": "Rostom A., Muir K., Dube C., Lanas A., Jolicoeur E., Tugwell P. Prevention of NSAID-related upper gastrointestinal toxicity: A meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc. Patient Saf. 2009;1:47\u201371. doi: 10.2147/DHPS.S4334.", "ArticleIdList": ["10.2147/DHPS.S4334", "PMC3108684", "21701610"]}, {"Citation": "Spechler S.J. Proton pump inhibitors: What the internist needs to know. Med. Clin. N. Am. 2019;103:1\u201314. doi: 10.1016/j.mcna.2018.08.001.", "ArticleIdList": ["10.1016/j.mcna.2018.08.001", "30466666"]}, {"Citation": "Lambert A.A., Lam J.O., Paik J.J., Ugarte-Gil C., Drummond M.B., Crowell T.A. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: A systematic review and meta-analysis. PLoS ONE. 2015;10:e0128004. doi: 10.1371/journal.pone.0128004.", "ArticleIdList": ["10.1371/journal.pone.0128004", "PMC4456166", "26042842"]}, {"Citation": "Kwok C.S., Arthur A.K., Anibueze C.I., Singh S., Cavallazzi R., Loke Y.K. Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: Meta-analysis. Am. J. Gastroenterol. 2012;107:1011\u20131019. doi: 10.1038/ajg.2012.108.", "ArticleIdList": ["10.1038/ajg.2012.108", "22525304"]}, {"Citation": "Deshpande A., Pasupuleti V., Thota P., Pant C., Mapara S., Hassan S., Rolston D.D., Sferra T.J., Hernandez A.V. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis. J. Gastroenterol. Hepatol. 2013;28:235\u2013242. doi: 10.1111/jgh.12065.", "ArticleIdList": ["10.1111/jgh.12065", "23190338"]}, {"Citation": "Haigh C.R., Attwood S.E., Thompson D.G., Jankowski J.A., Kirton C.M., Pritchard D.M., Varro A., Dimaline R. Gastrin induces proliferation in Barrett\u2019s metaplasia through activation of the CCK2 receptor. Gastroenterology. 2003;124:615\u2013625. doi: 10.1053/gast.2003.50091.", "ArticleIdList": ["10.1053/gast.2003.50091", "12612900"]}, {"Citation": "Laine L., Ahnen D., McClain C., Solcia E., Walsh J.H. Review article: Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment. Pharmacol. Ther. 2000;14:651\u2013668. doi: 10.1046/j.1365-2036.2000.00768.x.", "ArticleIdList": ["10.1046/j.1365-2036.2000.00768.x", "10848649"]}, {"Citation": "Lam J.R., Schneider J.L., Zhao W., Corley D.A. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310:2435\u20132442. doi: 10.1001/jama.2013.280490.", "ArticleIdList": ["10.1001/jama.2013.280490", "24327038"]}, {"Citation": "Koivisto T.T., Rautelin H.I., Voutilainen M.E., Heikkinen M.T., Koskenpato J.P., F\u00e4rkkil\u00e4 M.A. First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: Results of three eradication regimens. Aliment. Pharmacol. Ther. 2005;21:773\u2013782. doi: 10.1111/j.1365-2036.2005.02398.x.", "ArticleIdList": ["10.1111/j.1365-2036.2005.02398.x", "15771764"]}, {"Citation": "Lew E.A. Review article: Pharmacokinetic concerns in the selection of anti-ulcer therapy. Aliment. Pharmacol. Ther. 1999;13(Suppl. S5):11\u201316. doi: 10.1046/j.1365-2036.1999.00034.x.", "ArticleIdList": ["10.1046/j.1365-2036.1999.00034.x", "10555604"]}, {"Citation": "Gilard M., Arnaud B., Le Gal G., Abgrall J.F., Boschat J. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin. J. Thromb. Haemost. 2006;4:2508\u20132509. doi: 10.1111/j.1538-7836.2006.02162.x.", "ArticleIdList": ["10.1111/j.1538-7836.2006.02162.x", "16898956"]}, {"Citation": "Ghebremariam Y.T., Lee J.C., LePendu P., Erlanson D.A., Slaviero A., Shah N.H., Leiper J.M., Cooke J.P. Response to letters regarding article, \u201cunexpected effect of proton pump inhibitors: Elevation of the cardiovascular risk factor asymmetric dimethylarginine\u201d. Circulation. 2014;129:e428. doi: 10.1161/CIRCULATIONAHA.114.009343.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.114.009343", "PMC4105215", "24687654"]}, {"Citation": "Merwat S.N., Spechler S.J. Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am. J. Gastroenterol. 2009;104:1897\u20131902. doi: 10.1038/ajg.2009.87.", "ArticleIdList": ["10.1038/ajg.2009.87", "19661930"]}, {"Citation": "Lanas A. We are using too many PPIs, and we need to stop: A European perspective. Am. J. Gastroenterol. 2016;111:1085\u20131086. doi: 10.1038/ajg.2016.166.", "ArticleIdList": ["10.1038/ajg.2016.166", "27166129"]}, {"Citation": "Wong G.L., Wong V.W., Chan Y., Ching J.Y., Au K., Hui A.J., Lai L.H., Chow D.K., Siu D.K., Lui Y.N., et al. High incidence of mortality and recurrent bleeding in patients with helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525\u2013531. doi: 10.1053/j.gastro.2009.05.006.", "ArticleIdList": ["10.1053/j.gastro.2009.05.006", "19445937"]}, {"Citation": "Debraekeleer A., Remaut H. Future perspective for potential helicobacter pylori eradication therapies. Future Microbiol. 2018;13:671\u2013687. doi: 10.2217/fmb-2017-0115.", "ArticleIdList": ["10.2217/fmb-2017-0115", "29798689"]}, {"Citation": "Rates S.M. Plants as source of drugs. Toxicon. 2001;39:603\u2013613. doi: 10.1016/S0041-0101(00)00154-9.", "ArticleIdList": ["10.1016/S0041-0101(00)00154-9", "11072038"]}, {"Citation": "Yesilada E., G\u00fcrb\u00fcz I., Shibata H. Screening of Turkish antiulcerogenic folk remedies for anti-Helicobacter pylori activity. J. Ethnopharmacol. 1999;66:289\u2013293. doi: 10.1016/S0378-8741(98)00219-0.", "ArticleIdList": ["10.1016/S0378-8741(98)00219-0", "10473175"]}, {"Citation": "Falc\u00e3o H.S., Mariath I.R., Diniz M.F., Batista L.M., Barbosa-Filho J.M. Plants of the American continent with antiulcer activity. Phytomedicine. 2008;15:132\u2013146. doi: 10.1016/j.phymed.2007.07.057.", "ArticleIdList": ["10.1016/j.phymed.2007.07.057", "17904832"]}, {"Citation": "Chanda S., Baravalia Y., Kaneria M. Protective effect of Polyalthia longifolia var. Pendula leaves on ethanol and ethanol/HCL induced ulcer in rats and its antimicrobial potency. Asian Pac. J. Trop. Med. 2011;4:673\u2013679. doi: 10.1016/S1995-7645(11)60172-7.", "ArticleIdList": ["10.1016/S1995-7645(11)60172-7", "21967687"]}, {"Citation": "Palle S., Kanakalatha A., Kavitha C.N. Gastroprotective and antiulcer effects of Celastrus paniculatus seed oil against several gastric ulcer models in rats. J. Diet. Suppl. 2018;15:373\u2013385. doi: 10.1080/19390211.2017.1349231.", "ArticleIdList": ["10.1080/19390211.2017.1349231", "28816560"]}, {"Citation": "Abdallah E.M. Plants: An alternative source for antimicrobials. J. Appl. Pharm. Sci. 2011;1:16\u201320."}, {"Citation": "Silva N.C.C., Fernandes J\u00fanior A. Biological properties of medicinal plants: A review of their antimicrobial activity. J. Venom. Anim. Toxins Include. Trop. Dis. 2010;16:402\u2013413. doi: 10.1590/S1678-91992010000300006.", "ArticleIdList": ["10.1590/S1678-91992010000300006"]}, {"Citation": "Dikid T., Jain S.K., Sharma A., Kumar A., Narain J.P. Emerging & re-emerging infections in India: An overview. Indian J. Med. Res. 2013;138:19\u201331.", "ArticleIdList": ["PMC3767269", "24056553"]}, {"Citation": "Abdallah E.M. Medicinal plants with antibacterial properties against helicobacter pylori: A brief review. Curr. Trends Nutraceuticals. 2016;1:3."}, {"Citation": "Langmead L., Rampton D.S. Review article: Herbal treatment in gastrointestinal and liver disease\u2014Benefits and dangers. Aliment. Pharmacol. Ther. 2001;15:1239\u20131252. doi: 10.1046/j.1365-2036.2001.01053.x.", "ArticleIdList": ["10.1046/j.1365-2036.2001.01053.x", "11552894"]}, {"Citation": "Meshram N., Ojha M., Singh A., Alexander A., Sharma M. Significance of medicinal plant used for the treatment of peptic ulcer. Asian J. Pharm. Technol. 2015;5:32\u201337. doi: 10.5958/2231-5713.2015.00007.0.", "ArticleIdList": ["10.5958/2231-5713.2015.00007.0"]}, {"Citation": "Ricci V., Zarrilli R., Romano M. Voyage of helicobacter pylori in human stomach: Odyssey of a bacterium. Dig. Liver Dis. 2002;34:2\u20138. doi: 10.1016/S1590-8658(02)80051-2.", "ArticleIdList": ["10.1016/S1590-8658(02)80051-2", "11926570"]}, {"Citation": "Mital B., Kansara A.J.J. Possible interactions between garlic and conventional drugs: A review. Pharm. Biol. Eval. 2017;4:73\u201381."}, {"Citation": "Tuorkey M., Karolin K. Anti-ulcer activity of curcumin one experimental gastric ulcer in rats and its effect on oxidative stress/antioxidant, IL-6 and enzyme activities. Biomed. Environ. Sci. 2009;22:488\u2013495. doi: 10.1016/S0895-3988(10)60006-2.", "ArticleIdList": ["10.1016/S0895-3988(10)60006-2", "20337222"]}, {"Citation": "Pan M.H., Hsieh M.C., Hsu P.C., Ho S.Y., Lai C.S., Wu H., Sang S., Ho C.T. 6-shogaol suppressed lipopolysaccharide-induced up-expression of inos and cox-2 in murine macrophages. Mol. Nutr. Food Res. 2008;52:1467\u20131477. doi: 10.1002/mnfr.200700515.", "ArticleIdList": ["10.1002/mnfr.200700515", "18683823"]}, {"Citation": "Siddaraju M.N., Dharmesh S.M. Inhibition of gastric H+, K+-ATPase and helicobacter pylori growth by phenolic antioxidants of Zingiber officinale. Mol. Nutr. Food Res. 2007;51:324\u2013332. doi: 10.1002/mnfr.200600202.", "ArticleIdList": ["10.1002/mnfr.200600202", "17295419"]}, {"Citation": "Sripramote M., Lekhyananda N. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. J. Med. Assoc. Thail. 2003;86:846\u2013853.", "ArticleIdList": ["14649969"]}, {"Citation": "Ust\u00fcn O., Oz\u00e7elik B., Aky\u00f6n Y., Abbasoglu U., Yesilada E. Flavonoids with anti-Helicobacter pylori activity from Cistus laurifolius leaves. J. Ethnopharmacol. 2006;108:457\u2013461. doi: 10.1016/j.jep.2006.06.001.", "ArticleIdList": ["10.1016/j.jep.2006.06.001", "16870372"]}, {"Citation": "Asher G.N., Corbett A.H., Hawke R.L. Common herbal dietary supplement-drug interactions. Am. Fam. Physician. 2017;96:101\u2013107.", "ArticleIdList": ["28762712"]}, {"Citation": "Amber Nawab N.F. Review on green tea constituents and its negative effects. Pharm. Innov. J. 2015;4:21\u201324."}, {"Citation": "Vakil N. Helicobacter pylori treatment: A practical approach. Am. J. Gastroenterol. 2006;101:497\u2013499. doi: 10.1111/j.1572-0241.2006.00454.x.", "ArticleIdList": ["10.1111/j.1572-0241.2006.00454.x", "16542285"]}, {"Citation": "Campo S.M., Zullo A., Hassan C., Morini S. Antibiotic treatment strategies for Helicobacter pylori infection. Recent Pat. Antiinfect. Drug Discov. 2007;2:11\u201317. doi: 10.2174/157489107779561706.", "ArticleIdList": ["10.2174/157489107779561706", "18221161"]}, {"Citation": "Han S.U., Kim Y.B., Joo H.J., Hahm K.B., Lee W.H., Cho Y.K., Kim D.Y., Kim M.W. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J. Gastroenterol. Hepatol. 2002;17:253\u2013261. doi: 10.1046/j.1440-1746.2002.02684.x.", "ArticleIdList": ["10.1046/j.1440-1746.2002.02684.x", "11982694"]}, {"Citation": "Lee S.Y., Shin Y.W., Hahm K.B. Phytoceuticals: Mighty but ignored weapons against Helicobacter pylori infection. J. Dig. Dis. 2008;9:129\u2013139. doi: 10.1111/j.1751-2980.2008.00334.x.", "ArticleIdList": ["10.1111/j.1751-2980.2008.00334.x", "18956590"]}, {"Citation": "Kim D.K., Lee J.A., Kim Y.B., Lee K.M., Hahm K.B. A randomized controlled trial assessing Korea red ginseng treatment of Helicobacter pylori-associated chronic gastritis. Korean J. Med. 2007;72:20\u201328."}, {"Citation": "Park S., Yeo M., Jin J.H., Lee K.M., Jung J.Y., Choue R., Cho S.W., Hahm K.B. Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng. Dig. Dis. Sci. 2005;50:1218\u20131227. doi: 10.1007/s10620-005-2763-x.", "ArticleIdList": ["10.1007/s10620-005-2763-x", "16047463"]}, {"Citation": "Park J.M., Han Y.M., Kangwan N., Lee S.Y., Jung M.K., Kim E.H., Hahm K.B. S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition. J. Gastroenterol. Hepatol. 2014;29(Suppl. S4):80\u201392. doi: 10.1111/jgh.12730.", "ArticleIdList": ["10.1111/jgh.12730", "25521739"]}, {"Citation": "Iimuro M., Shibata H., Kawamori T., Matsumoto T., Arakawa T., Sugimura T., Wakabayashi K. Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett. 2002;187:61\u201368. doi: 10.1016/S0304-3835(02)00401-9.", "ArticleIdList": ["10.1016/S0304-3835(02)00401-9", "12359352"]}, {"Citation": "Trio P.Z., You S., He X., He J., Sakao K., Hou D.X. Chemopreventive functions and molecular mechanisms of garlic organosulfur compounds. Food Funct. 2014;5:833\u2013844. doi: 10.1039/c3fo60479a.", "ArticleIdList": ["10.1039/c3fo60479a", "24664286"]}, {"Citation": "Ca\u00f1izares P., Gracia I., G\u00f3mez L.A., Mart\u00edn de Argila C., Boixeda D., Garc\u00eda A., de Rafael L. Allyl-thiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol. Prog. 2004;20:397\u2013401. doi: 10.1021/bp034143b.", "ArticleIdList": ["10.1021/bp034143b", "14763870"]}, {"Citation": "Bovicelli P., D\u2019Angelo V., Collalto D., Verzina A., D\u2019Antona N., Lambusta D. Efficient synthesis of polyoxygenated flavones from naturally occurring flavanones. J. Pharm. Pharmacol. 2007;59:1697\u20131701. doi: 10.1211/jpp.59.12.0012.", "ArticleIdList": ["10.1211/jpp.59.12.0012", "18053332"]}, {"Citation": "Li H.Q., Xu C., Li H.S., Xiao Z.P., Shi L., Zhu H.L. Metronidazole-flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells. ChemMedChem. 2007;2:1361\u20131369. doi: 10.1002/cmdc.200700097.", "ArticleIdList": ["10.1002/cmdc.200700097", "17628869"]}, {"Citation": "Afdhal N., Reddy K.R., Nelson D.R., Lawitz E., Gordon S.C., Schiff E., Nahass R., Ghalib R., Gitlin N., Herring R., et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N. Engl. J. Med. 2014;370:1483\u20131493. doi: 10.1056/NEJMoa1316366.", "ArticleIdList": ["10.1056/NEJMoa1316366", "24725238"]}, {"Citation": "Banerjee S., Mullick H.I., Banerjee J., Ghosh A. Zingiber officinale: A natural gold. Int. J. Pharm. Bio-Sci. 2011;2:283\u2013294."}, {"Citation": "Jiang S.Z., Wang N.S., Mi S.Q. Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats. Biopharm. Drug Dispos. 2008;29:529\u2013537. doi: 10.1002/bdd.638.", "ArticleIdList": ["10.1002/bdd.638", "19051331"]}, {"Citation": "Sidahmed H.M., Hashim N.M., Abdulla M.A., Ali H.M., Mohan S., Abdelwahab S.I., Taha M.M., Fai L.M., Vadivelu J. Antisecretory, gastroprotective, antioxidant and anti-Helicobcter pylori activity of Zerumbone from Zingiber zerumbet (l.) smith. PLoS ONE. 2015;10:e0121060. doi: 10.1371/journal.pone.0121060.", "ArticleIdList": ["10.1371/journal.pone.0121060", "PMC4370679", "25798602"]}, {"Citation": "Fujiki H., Suganuma M., Okabe S., Kurusu M., Imai K., Nakachi K. Involvement of TNF-alpha changes in human cancer development, prevention and palliative care. Mech. Ageing Dev. 2002;123:1655\u20131663. doi: 10.1016/S0047-6374(02)00101-X.", "ArticleIdList": ["10.1016/S0047-6374(02)00101-X", "12470903"]}, {"Citation": "Matsubara S., Shibata H., Ishikawa F., Yokokura T., Takahashi M., Sugimura T., Wakabayashi K. Suppression of helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem. Biophys. Res. Commun. 2003;310:715\u2013719. doi: 10.1016/j.bbrc.2003.09.066.", "ArticleIdList": ["10.1016/j.bbrc.2003.09.066", "14550260"]}, {"Citation": "Ruggiero P., Rossi G., Tombola F., Pancotto L., Lauretti L., Del Giudice G., Zoratti M. Red wine and green tea reduce H pylori- or VacA-induced gastritis in a mouse model. World J. Gastroenterol. 2007;13:349\u2013354. doi: 10.3748/wjg.v13.i3.349.", "ArticleIdList": ["10.3748/wjg.v13.i3.349", "PMC4065887", "17230601"]}, {"Citation": "Rao C.V., Verma A.R., Vijayakumar M., Rastogi S. Gastroprotective effect of standardized extract of Ficus glomerata fruit on experimental gastric ulcers in rats. J. Ethnopharmacol. 2008;115:323\u2013326. doi: 10.1016/j.jep.2007.09.019.", "ArticleIdList": ["10.1016/j.jep.2007.09.019", "17980529"]}, {"Citation": "Salehi M. Medicinal plants for management of gastroesophageal reflux disease: A review of animal and human studies. J. Altern. Complement. Med. 2010;23:82\u201395. doi: 10.1089/acm.2016.0233.", "ArticleIdList": ["10.1089/acm.2016.0233", "27996295"]}, {"Citation": "Oh T.Y., Lee J.S., Ahn B.O., Cho H., Kim W.B., Kim Y.B., Surh Y.J., Cho S.W., Hahm K.B. Oxidative damages are critical in pathogenesis of reflux esophagitis: Implication of antioxidants in its treatment. Free Radic. Biol. Med. 2001;30:905\u2013915. doi: 10.1016/S0891-5849(01)00472-5.", "ArticleIdList": ["10.1016/S0891-5849(01)00472-5", "11295533"]}, {"Citation": "Mahattanadul S., Radenahmad N., Phadoongsombut N., Chuchom T., Panichayupakaranant P., Yano S., Reanmongkol W. Effects of curcumin on reflux esophagitis in rats. J. Nat. Med. 2006;60:198\u2013205. doi: 10.1007/s11418-006-0036-4.", "ArticleIdList": ["10.1007/s11418-006-0036-4", "29435885"]}, {"Citation": "Hajda J., Rentsch K.M., Gubler C., Steinert H., Stieger B., Fattinger K. Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. Eur. J. Pharm. Sci. 2010;41:729\u2013735. doi: 10.1016/j.ejps.2010.09.016.", "ArticleIdList": ["10.1016/j.ejps.2010.09.016", "20933082"]}, {"Citation": "Alissa E.M. Medicinal herbs and therapeutic drugs interactions. Ther. Drug Monit. 2014;36:413\u2013422. doi: 10.1097/FTD.0000000000000035.", "ArticleIdList": ["10.1097/FTD.0000000000000035", "24452064"]}, {"Citation": "Jiang X., Williams K.M., Liauw W.S., Ammit A.J., Roufogalis B.D., Duke C.C., Day R.O., McLachlan A.J. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br. J. Clin. Pharmacol. 2005;59:425\u2013432. doi: 10.1111/j.1365-2125.2005.02322.x.", "ArticleIdList": ["10.1111/j.1365-2125.2005.02322.x", "PMC1884814", "15801937"]}, {"Citation": "Abebe W. Herbal medication: Potential for adverse interactions with analgesic drugs. J. Clin. Pharm. Ther. 2002;27:391\u2013401. doi: 10.1046/j.1365-2710.2002.00444.x.", "ArticleIdList": ["10.1046/j.1365-2710.2002.00444.x", "12472978"]}, {"Citation": "Malati C.Y., Robertson S.M., Hunt J.D., Chairez C., Alfaro R.M., Kovacs J.A., Penzak S.R. Influence of panax ginseng on cytochrome p450 (CYP)3a and p-glycoprotein (P-gp) activity in healthy participants. J. Clin. Pharmacol. 2012;52:932\u2013939. doi: 10.1177/0091270011407194.", "ArticleIdList": ["10.1177/0091270011407194", "PMC3523324", "21646440"]}, {"Citation": "Zhou S., Lim L.Y., Chowbay B. Herbal modulation of p-glycoprotein. Drug Metab. Rev. 2004;36:57\u2013104. doi: 10.1081/DMR-120028427.", "ArticleIdList": ["10.1081/DMR-120028427", "15072439"]}, {"Citation": "Werba J.P., Giroli M., Cavalca V., Nava M.C., Tremoli E., Dal Bo L. The effect of green tea on simvastatin tolerability. Ann. Int. Med. 2008;149:286\u2013287. doi: 10.7326/0003-4819-149-4-200808190-00019.", "ArticleIdList": ["10.7326/0003-4819-149-4-200808190-00019", "18711168"]}, {"Citation": "Sorkin E.M., Darvey D.L. Review of cimetidine drug interactions. Drug Intell. Clin. Pharm. 1983;17:110\u2013120. doi: 10.1177/106002808301700205.", "ArticleIdList": ["10.1177/106002808301700205", "6130930"]}, {"Citation": "Feely J. Interaction of cimetidine with other drugs. S. Med. J. 1983;76:753\u2013758. doi: 10.1097/00007611-198306000-00020.", "ArticleIdList": ["10.1097/00007611-198306000-00020", "6344228"]}, {"Citation": "Broughton L.J., Rogers H.J. Decreased systemic clearance of caffeine due to cimetidine. Br. J. Clin. Pharmacol. 1981;12:155\u2013159. doi: 10.1111/j.1365-2125.1981.tb01194.x.", "ArticleIdList": ["10.1111/j.1365-2125.1981.tb01194.x", "PMC1401851", "7306430"]}]}], "History": [{"Year": "2018", "Month": "12", "Day": "31"}, {"Year": "2019", "Month": "1", "Day": "30"}, {"Year": "2019", "Month": "1", "Day": "31"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "2", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["30717467", "PMC6406303", "10.3390/jcm8020179", "jcm8020179"]}}]}